Diabetes Research Unit, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Centre for Diabetes Endocrinology and Metabolism, Colombo, Sri Lanka.
Diabet Med. 2024 Dec;41(12):e15422. doi: 10.1111/dme.15422. Epub 2024 Aug 8.
Very low-calorie diet (VLCD) can induce weight loss and diabetes remission (DR) amongst people with obesity and recent-onset type 2 diabetes (T2D). We aimed to determine the effectiveness and acceptability of VLCD in achieving DR amongst Sri Lankan adults with T2D.
A retrospective analysis was conducted in a diabetes practice where VLCD-based Diabetes Remission Programme (VDRP) was offered for adults (>18 years) with T2D for <3 years and body mass index over 25 kg/m. VLCD (~800 kcal/day, provided with/without diet replacement formula) was offered for 8-12 weeks, followed by gradual food reintroduction and exercise. DR was defined as HbA1c <6.5% at least 3 months after stopping glucose-lowering medications.
A total of 170 participants who enrolled in the VDRP (mean age 38.4 years [±11.1], men 68%, mean baseline HbA1c 86.9 [±18.1] mmol/mol (10.1 [±2.1]%), median duration of T2D 2 years [IQR 1-2]) and 87 (51%) of them followed the programme (attended at least one follow-up visit). Amongst the individuals who followed the VDRP, 40.2% achieved DR (35/87), compared with 2.4% (2/83) amongst those who did not follow the VDRP (aHR 9.3, 95% CI 2.2-16.4, p = 0.002). The proportion achieving normoglycaemia (HbA1c < 6.5%) but continued to take glucose-lowering medication was 20/87 among VDRP followers and 20/85 amongst VDRP non-followers. The commonest reasons for not following the VDRP were too restrictive dietary quantity (92%) and difficulties in finding recommended food items (67%). Majority (79%) would recommend VDRP to others.
VDRP is effective in achieving T2D remission amongst Sri Lankan adults with recently diagnosed T2D and obesity. Over half of the participants followed the programme and over 75% would recommend it to others, indicating good acceptability.
极低卡路里饮食(VLCD)可诱导肥胖和近期诊断出 2 型糖尿病(T2D)的人群减轻体重并实现糖尿病缓解(DR)。本研究旨在确定 VLCD 在实现斯里兰卡 T2D 成人 DR 方面的有效性和可接受性。
在一个糖尿病诊所进行了回顾性分析,该诊所提供了针对 T2D 病程<3 年且 BMI 超过 25kg/m²的成年人的基于 VLCD 的糖尿病缓解计划(VDRP)。VLCD(~800kcal/天,提供或不提供饮食替代配方)持续 8-12 周,随后逐渐引入食物并进行锻炼。DR 定义为停止降糖药物至少 3 个月后 HbA1c<6.5%。
共有 170 名参加 VDRP 的参与者(平均年龄 38.4±11.1 岁,男性占 68%,平均基线 HbA1c 为 86.9±18.1mmol/mol(10.1±2.1%),中位 T2D 病程为 2 年[IQR 1-2]),其中 87 名(51%)参与者完成了该计划(至少参加了一次随访)。在完成 VDRP 的参与者中,40.2%(35/87)实现了 DR,而未完成 VDRP 的参与者中仅 2.4%(2/83)实现了 DR(aHR 9.3,95%CI 2.2-16.4,p=0.002)。在完成 VDRP 的参与者中,20/87(23%)实现了血糖正常(HbA1c<6.5%)但仍在服用降糖药物,而未完成 VDRP 的参与者中这一比例为 20/85(24%)。不遵循 VDRP 的最常见原因是饮食量限制太严格(92%)和难以找到推荐的食物(67%)。大多数(79%)人会向他人推荐 VDRP。
VDRP 可有效实现斯里兰卡近期诊断出 T2D 合并肥胖的成年人的 T2D 缓解。超过一半的参与者遵循了该计划,超过 75%的参与者会向他人推荐该计划,表明其具有良好的可接受性。